Joel Smolen is a seasoned hedge fund manager, venture capitalist and chief executive who has been creating value for clients and investors for over forty years. He is currently CEO of Axion Capital Management, LLC and personally manages the Axion Opportunity Fund, which he founded in 2001. Joel also sits on the Board of Directors for AmpliMed Corporation, a biotech drug discovery company founded in 1989, which has multiple drugs in late phase clinical trials.
Joel was a pioneer in the metallurgy and emerging electronics industry, and consulted and worked with Intel, Apple, IBM, AMD, and National Semiconductor in the 70’s and 80’s. He founded and was CEO of Applied Molecular Technology Corporation, which was sold to Boliden AB, a billion-dollar European metals company. Prior to that, Joel was founder and CEO of MicroMetallics Corporation, which was sold to Xstrata PLC, (XTA.L) an international metals and mining company with over 20,000 employees in 2008. Joel was also Senior Vice President of LMC Corporation, now part of Sims Metal Management (SMS), a worldwide metals company. Joel also created two business parks, and built over a million feet of office space in the San Francisco Bay Area.
In 1999 Joel became a registered investment adviser and began concentrating on individual investor and private equity investments.
Specialties: Investment opportunities in the technology, commodities, metals and energy, sectors, private equity and wealth advisory services